Influenza virus hemagglutinin influenza virus neuraminidase

Influenza Virus Hemagglutinin (HA) (H7N9) Fc tag

Product TypeMammalian recombinant, his-tagged
Purity>95% pure by SDS-PAGE
StrainA/Shanghai/2/2013
PresentationLyophilised
Protein Conc.n/a
Product CodeFLU-H7N9-HAFC
Vial Size100μg | 1mg

From: $581.25

Clear
SKU: FLU-H7N9-HAFC Categories: ,

Product Description

FLUH7N9-HA1FC-100 Batch L16080212 CofA

NAC MSDS FLUH7N9-HA1FC

Influenza Viruses

Influenza, commonly known as “the flu”, is an infectious disease of birds and mammals caused by RNA viruses of the family Orthomyxoviridae, the influenza viruses. The virus is divided into three main types (Influenza virus A, Influenza virus B, and Influenza virus C), which are distinguished by differences in two major internal proteins (hemagglutinin (HA) and neuraminidase (NA), which are the most important targets for the immune system. The type A viruses are the most virulent human pathogens among the three influenza types and cause the most severe disease.

Influenza virus hemagglutinin (HA)

Influenza virus hemagglutinin (HA) is a trimer of identical subunits, each of which contains two polypeptides that result from proteolytic cleavage of a single precursor.  The two polypeptides are designated HA1 and HA2. The HA2 monomer is a long helical chain, anchored into the membrane, and is “topped” by a “globule” of HA1. Cleavage of the precursor is essential for activation of membrane fusion potential and hence infectivity.  For HAs of most subtypes, the site of cleavage is a single arginine residue, and cleavage occurs extracellularly by an as yet unidentified enzyme. However, some members of the H5 and H7 subtypes have acquired a series of basic residues at the cleavage site, which are recognized by an intracellular subtilisin-like enzyme. In these cases, cleavage is efficient, virus infectivity is high, and the viruses are highly pathogenic. The avian H5 influenza, which continues to spread throughout the world, excluding the Americas, is caused by such viruses.   The structure of HA has been reviewed by Gamblin and Skehel in 2010.

This Influenza virus hemagglutinin protein is derived from the HA sequence of the A/Shanghai/2/2013 (H7N9) strain, expressing Asp19 – Asp521, and is fused with the Fc region of human IgG1 at the C-terminus. The total calculated MW is 84.5kDa.   The influenza virus hemagglutinin protein is expressed in HEK293 cells, and DTT-reduced protein migrates as a band of 110-120kDa. 

 

****SHIPPING AND STORAGE NOTIFICATION: This recombinant protein has been lyophilised to maximise stability.  It is shipped at ambient temperature, and may be stored for up to 1 year at 4C prior to reconstitution.  Following reconstitution it should be stored at -80C. Extensive stability tests have shown no negative effects on antigen performance for 7 days of shipping at ambient temperature. 

Additional Information

Vial Size

100μg, 1mg

FLUH7N9-HA1FC-100 Batch L16080212 CofA  FLUH7N9-HA1FC-100 Batch L16080212 CofA

NAC MSDS FLUH7N9-HA1FC  NAC MSDS FLUH7N9-HA1FC

Menu